Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance
Demiroglu Science University Florence Nightingale Journal of Medicine · 26.09.2025 · 11 (2) · 83-87
DOI: 10.5606/fng.btd.2025.189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Demiroglu Science University Florence Nightingale Journal of Medicine, online erschienen am 26.09.2025. Verfasst von Şara Alagöz.
Abstract (Originalsprache)
Objectives: This study explores the interaction between HOX transcript antisense RNA (HOTAIR) and miR-29b-3p across three different breast cancer subtypes, aiming to identify new potential therapeutic targets. Materials and methods: Quantitative polymerase chain reaction was used to analyze the expression levels of HOTAIR and miR-29b-3p in three breast cancer cell lines: MCF-7 (estrogen receptor-positive: ER+), MDA-MB-453 (human epidermal growth factor receptor 2-positive: HER2+), and MDA-MB-231 (triple-negative breast cancer: TNBC). MCF-10A cells were used as the normal control. GAPDH and U6 served as housekeeping genes. Gene expression was calculated using the 2-∆∆Ct method, with statistical significance defined as p
Zitieren
APA
Alagöz, Ş. (2025). Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance. Demiroglu Science University Florence Nightingale Journal of Medicine, 11(2), 83-87. https://doi.org/10.5606/fng.btd.2025.189
Vancouver
Alagöz Ş. Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance. Demiroglu Science University Florence Nightingale Journal of Medicine. 2025;11(2):83-87. doi:10.5606/fng.btd.2025.189
BibTeX
@article{Alagz2025,
author = {Alagöz, Şara},
title = {Expression profiles and regulatory crosstalk of lncRNA HOTAIR and miR-29b-3p across breast cancer subtypes: Implications for tumor progression and therapy resistance},
journal = {Demiroglu Science University Florence Nightingale Journal of Medicine},
year = {2025},
volume = {11},
number = {2},
pages = {83--87},
doi = {10.5606/fng.btd.2025.189}
}
EUVIMED